| 1 | [SID26543390] | Chemical Probe | | | Summary of probe development efforts to identify inhibitors of Toll-Like Receptor 4 (TLR4). [AID1953, Type: summary] | toll-like receptor 4 [Homo sapiens] [gi:55662034] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 26543390 | | CID | 5716367 | | Outcome | Chemical Probe | | BioAssay | Summary of probe development efforts to identify inhibitors of Toll-Like Receptor 4 (TLR4). | | AID | 1953 | | BioAssay type | summary | | Target | toll-like receptor 4 [Homo sapiens] [gi:55662034] | | PubMed | | | Data Table |  |
|
| 2 | [SID99495574] | Active | Potency | 0.0517 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | Potency | 0.0517 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 3 | [SID99495574] | Active | Potency | 0.0517 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | Potency | 0.0517 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 4 | [SID99495574] | Active | Potency | 0.0517 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | Potency | 0.0517 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 5 | [SID99495574] | Active | Potency | 0.058 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | Potency | 0.058 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID99495574] | Active | Potency | 0.058 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | Potency | 0.058 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID99495574] | Active | Potency | 0.058 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | Potency | 0.058 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 8 | [SID99495574] | Active | Potency | 1.1582 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line [AID686971, Type: confirmatory] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | Potency | 1.1582 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line | | AID | 686971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID99495574] | Active | Potency | 7.3078 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | Potency | 7.3078 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 10 | [SID99495574] | Active | Potency | 7.3078 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | Potency | 7.3078 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 11 | [SID99495574] | Active | Potency | 7.3078 | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | Potency | 7.3078 [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 12 | [SID99495574] | Active | Potency | 7.9433 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 13 | [SID99495574] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) [AID686940, Type: screening] | NR2F2 gene product [Homo sapiens] [gi:14149746] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) | | AID | 686940 | | BioAssay type | screening | | Target | NR2F2 gene product [Homo sapiens] [gi:14149746] | | PubMed | | | Data Table |  |
|
| 14 | [SID99495574] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) [AID686940, Type: screening] | NR2F2 gene product [Homo sapiens] [gi:14149746] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) | | AID | 686940 | | BioAssay type | screening | | Target | NR2F2 gene product [Homo sapiens] [gi:14149746] | | PubMed | | | Data Table |  |
|
| 15 | [SID99495574] | Active | | | qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1) [AID624414, Type: screening] | MCOLN1 gene product [Homo sapiens] [gi:10092597] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1) | | AID | 624414 | | BioAssay type | screening | | Target | MCOLN1 gene product [Homo sapiens] [gi:10092597] | | PubMed | | | Data Table |  |
|
| 16 | [SID99495574] | Active | | | HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity [AID652154, Type: screening] | PAX8 [Homo sapiens] [gi:998701] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652154 | | BioAssay type | screening | | Target | PAX8 [Homo sapiens] [gi:998701] | | PubMed | | | Data Table |  |
|
| 17 | [SID99495574] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) [AID588352, Type: screening] | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) | | AID | 588352 | | BioAssay type | screening | | Target | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] | | PubMed | | | Data Table |  |
|
| 18 | [SID99495574] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) [AID588792, Type: screening] | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) | | AID | 588792 | | BioAssay type | screening | | Target | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] | | PubMed | | | Data Table |  |
|
| 19 | [SID99495574] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) [AID624466, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624466 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 20 | [SID99495574] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) [AID624466, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624466 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 21 | [SID99495574] | Active | | | Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3): Luminescence-based cell-based high throughput screening assay to identify agonists of the Herpes Virus Virion Protein 16 (VP16) [AID624379, Type: screening] | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3): Luminescence-based cell-based high throughput screening assay to identify agonists of the Herpes Virus Virion Protein 16 (VP16) | | AID | 624379 | | BioAssay type | screening | | Target | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] | | PubMed | | | Data Table |  |
|
| 22 | [SID99495574] | Active | | | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) [AID651615, Type: screening] | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Counterscreen for inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) | | AID | 651615 | | BioAssay type | screening | | Target | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] | | PubMed | | | Data Table |  |
|
| 23 | [SID99495574] | Active | | | Counterscreen for inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) [AID588794, Type: screening] | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16) | | AID | 588794 | | BioAssay type | screening | | Target | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] | | PubMed | | | Data Table |  |
|
| 24 | [SID99495574] | Active | | | Counterscreen for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16). [AID588824, Type: screening] | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1): Luminescence-based cell-based high throughput assay to identify inhibitors of the Herpes Virus Virion Protein 16 (VP16). | | AID | 588824 | | BioAssay type | screening | | Target | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] | | PubMed | | | Data Table |  |
|
| 25 | [SID99495574] | Active | | | Counterscreen for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and receptor-interacting serine-threonine kinase 2 (RIPK2): Fluorescence-based cell-based high throughput assay to identify non-selective inhibitors of the beta-lactamase enzyme (BLA) [AID624371, Type: screening] | Beta lactamase [Pseudomonas aeruginosa] [gi:114881106] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and receptor-interacting serine-threonine kinase 2 (RIPK2): Fluorescence-based cell-based high throughput assay to identify non-selective inhibitors of the beta-lactamase enzyme (BLA) | | AID | 624371 | | BioAssay type | screening | | Target | Beta lactamase [Pseudomonas aeruginosa] [gi:114881106] | | PubMed | | | Data Table |  |
|
| 26 | [SID99495574] | Active | | | S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity [AID652163, Type: screening] | S100A4 [Homo sapiens] [gi:47496637] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652163 | | BioAssay type | screening | | Target | S100A4 [Homo sapiens] [gi:47496637] | | PubMed | | | Data Table |  |
|
| 27 | [SID26543390] | Active | | | Fluorescence-based cell-based confirmation assay for antagonists of kappa opioid receptor 1 (OPRK1) [AID652082, Type: other] | opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 26543390 | | CID | 5716367 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based confirmation assay for antagonists of kappa opioid receptor 1 (OPRK1) | | AID | 652082 | | BioAssay type | other | | Target | opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] | | PubMed | | | Data Table |  |
|
| 28 | [SID26543390] | Active | | | Fluorescence-based cell-based confirmation assay for antagonists of kappa opioid receptor 1 (OPRK1) [AID652082, Type: other] | opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26543390 | | CID | 5716367 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based confirmation assay for antagonists of kappa opioid receptor 1 (OPRK1) | | AID | 652082 | | BioAssay type | other | | Target | opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] | | PubMed | | | Data Table |  |
|
| 29 | [SID26543390] | Active | | | Fluorescence-based cell-based confirmation assay for antagonists of kappa opioid receptor 1 (OPRK1) [AID652082, Type: other] | opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26543390 | | CID | 5716367 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based confirmation assay for antagonists of kappa opioid receptor 1 (OPRK1) | | AID | 652082 | | BioAssay type | other | | Target | opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] | | PubMed | | | Data Table |  |
|
| 30 | [SID26543390] | Active | | | Fluorescence-based cell-based confirmation assay for antagonists of kappa opioid receptor 1 (OPRK1) [AID652082, Type: other] | opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26543390 | | CID | 5716367 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based confirmation assay for antagonists of kappa opioid receptor 1 (OPRK1) | | AID | 652082 | | BioAssay type | other | | Target | opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] | | PubMed | | | Data Table |  |
|
| 31 | [SID26543390] | Active | | | Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay [AID652031, Type: screening] | opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26543390 | | CID | 5716367 | | Outcome | Active | | BioAssay | Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay | | AID | 652031 | | BioAssay type | screening | | Target | opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] | | PubMed | | | Data Table |  |
|
| 32 | [SID26543390] | Active | | | Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay [AID652031, Type: screening] | opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26543390 | | CID | 5716367 | | Outcome | Active | | BioAssay | Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay | | AID | 652031 | | BioAssay type | screening | | Target | opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] | | PubMed | | | Data Table |  |
|
| 33 | [SID26543390] | Active | | | Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay [AID652031, Type: screening] | opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 26543390 | | CID | 5716367 | | Outcome | Active | | BioAssay | Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay | | AID | 652031 | | BioAssay type | screening | | Target | opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] | | PubMed | | | Data Table |  |
|
| 34 | [SID26543390] | Active | | | Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay [AID652031, Type: screening] | opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26543390 | | CID | 5716367 | | Outcome | Active | | BioAssay | Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay | | AID | 652031 | | BioAssay type | screening | | Target | opioid receptor, kappa 1 [Homo sapiens] [gi:119607129] | | PubMed | | | Data Table |  |
|
| 35 | [SID99495574] | Active | | | Counterscreen for antagonists of the galanin Receptor 3 (GalR3): Fluorescence-based cell-based high throughput screening assay to identify non specific agonists of the parental HEK-CNG cells [AID652268, Type: screening] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Counterscreen for antagonists of the galanin Receptor 3 (GalR3): Fluorescence-based cell-based high throughput screening assay to identify non specific agonists of the parental HEK-CNG cells | | AID | 652268 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID26543390] | Active | | | Primary Cell Based High Throughput Screening Assay for Inhibitors of TLR4-MyD88 binding [AID811, Type: screening] | toll-like receptor 4 [Homo sapiens] [gi:55662034] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26543390 | | CID | 5716367 | | Outcome | Active | | BioAssay | Primary Cell Based High Throughput Screening Assay for Inhibitors of TLR4-MyD88 binding | | AID | 811 | | BioAssay type | screening | | Target | toll-like receptor 4 [Homo sapiens] [gi:55662034] | | PubMed | | | Data Table |  |
|
| 37 | [SID99495574] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) [AID651719, Type: screening] | GALR3 gene product [Homo sapiens] [gi:4503907] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) | | AID | 651719 | | BioAssay type | screening | | Target | GALR3 gene product [Homo sapiens] [gi:4503907] | | PubMed | | | Data Table |  |
|
| 38 | [SID99495574] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) [AID651719, Type: screening] | GALR3 gene product [Homo sapiens] [gi:4503907] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) | | AID | 651719 | | BioAssay type | screening | | Target | GALR3 gene product [Homo sapiens] [gi:4503907] | | PubMed | | | Data Table |  |
|
| 39 | [SID99495574] | Active | | | Fluorescence-based cell-based primary high throughput confirmation assay to identify antagonists of the Galanin Receptor 3 (GalR3) [AID652245, Type: screening] | GALR3 gene product [Homo sapiens] [gi:4503907] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput confirmation assay to identify antagonists of the Galanin Receptor 3 (GalR3) | | AID | 652245 | | BioAssay type | screening | | Target | GALR3 gene product [Homo sapiens] [gi:4503907] | | PubMed | | | Data Table |  |
|
| 40 | [SID99495574] | Active | | | Fluorescence-based cell-based primary high throughput confirmation assay to identify antagonists of the Galanin Receptor 3 (GalR3) [AID652245, Type: screening] | GALR3 gene product [Homo sapiens] [gi:4503907] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput confirmation assay to identify antagonists of the Galanin Receptor 3 (GalR3) | | AID | 652245 | | BioAssay type | screening | | Target | GALR3 gene product [Homo sapiens] [gi:4503907] | | PubMed | | | Data Table |  |
|
| 41 | [SID99495574] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1). [AID588820, Type: screening] | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1). | | AID | 588820 | | BioAssay type | screening | | Target | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] | | PubMed | | | Data Table |  |
|
| 42 | [SID99495574] | Active | | | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1). [AID588820, Type: screening] | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1). | | AID | 588820 | | BioAssay type | screening | | Target | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] | | PubMed | | | Data Table |  |
|
| 43 | [SID99495574] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1) [AID588354, Type: screening] | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1) | | AID | 588354 | | BioAssay type | screening | | Target | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] | | PubMed | | | Data Table |  |
|
| 44 | [SID99495574] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1) [AID588354, Type: screening] | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1) | | AID | 588354 | | BioAssay type | screening | | Target | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] | | PubMed | | | Data Table |  |
|
| 45 | [SID99495574] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID624267, Type: screening] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 624267 | | BioAssay type | screening | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 46 | [SID99495574] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID624267, Type: screening] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 624267 | | BioAssay type | screening | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 47 | [SID99495574] | Active | | | Fluorescence-based cell-based high throughput confirmation assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID624370, Type: screening] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based high throughput confirmation assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 624370 | | BioAssay type | screening | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 48 | [SID99495574] | Active | | | Fluorescence-based cell-based high throughput confirmation assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID624370, Type: screening] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based high throughput confirmation assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 624370 | | BioAssay type | screening | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 49 | [SID99495574] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624378, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624378 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|
| 50 | [SID99495574] | Active | | | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) [AID624378, Type: screening] | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 99495574 | | CID | 5716367 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3) | | AID | 624378 | | BioAssay type | screening | | Target | photoreceptor-specific nuclear receptor [Homo sapiens] [gi:216409728] | | PubMed | | | Data Table |  |
|